ImmuPharma PLC
("ImmuPharma" or the "Company")
London Investor Evening
Monday 26 February 2018 @ 6pm
ImmuPharma PLC (LSE: IMM), specialist drug discovery and development company, is pleased to announce that Tim McCarthy, Chairman, will be presenting at an investor evening hosted by Turner Pope Investments (TPI) Ltd. TPI acted as agent in the recent £10 million fundraise by ImmuPharma.
The event will be held on Monday 26th February 2018 in London, EC2 and will commence at 6pm. Further details on the event will be provided upon registration. To Register your interest, please email [email protected] and [email protected] or call 0203 621 4120.
-Ends-
For further information please contact:
ImmuPharma plc (www.immupharma.org) |
+ 44 (0) 20 7152 4080 |
Tim McCarthy, Chairman |
|
Lisa Baderoon, Head of Investor Relations [email protected] Twitter: @immupharma |
+ 44 (0) 7721 413496 |
Northland Capital Partners Limited (NOMAD & Broker) David Hignell, Jamie Spotswood, Corporate Finance Rob Rees, Corporate Broking |
+44 (0)20 3861 6625 |
|
|
|
|
|
|
|
|
